Tools   Select Another Resource Report Type

https://www.ucl.ac.uk/biobank/physicalbloom

The UCL/UCLH Biobank for Studying Health and Disease has been primarily established to support the Research Programme and scientific needs, of the Pathology Department UCLH & the UCL Cancer Institute. The establishment of the core programme enables a centralised approach to the management and integration of all research groups working within these institutions, providing appropriate structure and support. The biobank has policies and guidelines to guarantee compliance with HTA legislation and to ensure quality standards will be maintained. The biobank stores normal and pathological specimens, surplus to diagnostic requirements, from relevant tissues and bodily fluids, as well as human tissue used in xenograft experiments. Stored tissues include; snap-frozen or cryopreserved tissue, formalin-fixed tissue, paraffin-embedded tissues, and slides prepared for histological examination. Tissues include resection specimens obtained surgically or by needle core biopsy. Bodily fluids include; whole blood, serum, plasma, urine, cerebrospinal fluid, milk, saliva and buccal smears and cytological specimens such as sputum and cervical smears. Fine needle aspirates obtained from tissues and bodily cavities (eg. pleura and peritoneum) are also collected. Where appropriate the biobank also stores separated cells, protein, DNA and RNA isolated from collected tissues and bodily fluids described above. Some of the tissue and aspirated samples are stored in the diagnostic archive.

Proper citation: UCL/UCLH Biobank for Studying Health and Disease (RRID:SCR_004610) Copy   

•   Source: SciCrunch Registry

http://www.sciencecare.com/

Science Care''s whole body donation program supports medical research, training and professional education, which provides enormous benefits to humankind. Given the increasing advancements in medical technologies, donation is of greater importance than ever. A life-affirming choice, donation is also a highly individual decision. In every way possible, Science Care honors that decision by adhering to the strictest guidelines and providing the most compassionate care. Science Care was founded in 2000 with the vision to become the world''s leading whole body donor program. Under the leadership of James Rogers, Founder and CEO, Science Care has accelerated research on many fronts leading to the development of new medical devices and safer, more effective treatments for patients. At Science Care, we provide the opportunity to make a final choice with control and dignity. Our donors know that their last act was donating to the welfare of humankind, and their gift provides a lasting legacy.

Proper citation: ScienceCare (RRID:SCR_004457) Copy   

•   Source: SciCrunch Registry

http://www.lifeshareoklahoma.org/

LifeShare Transplant Donor Services of Oklahoma strives to recover healthy, transplantable organs and tissues through careful screening and management of donors to provide the maximum number of lifesaving/life-enhancing organs and tissues for patients awaiting transplantation in Oklahoma. It is committed to providing a better quality of life for those people who require organ or tissue transplantation, while respecting and honoring those families who share the gift of life. LifeShare emphasizes a person''s decision to be an organ and tissue donor and whenever possible will honor the decision of the individual to donate. It works hard to provide education to the state of Oklahoma about organ, eye and tissue donation. Education is provided to medical professionals who identify and care for potential organ and tissue donors, and recognize donation as continuing to care for the patient and their family. LifeShare strongly supports research and development to improve the quality and availability of organs and tissues for transplantation and the success of human transplantation in general. It is also committed to providing support and comfort to grieving families who have suffered great loss.

Proper citation: LifeShare Transplant (RRID:SCR_004298) Copy   

•   Source: SciCrunch Registry

http://www.themmrf.org/research-programs/for-academic-researchers/tissue-bank.html

Until recently, a scarcity of high-quality myeloma tissue has posed one of the greatest challenges in advancing myeloma research and drug development. Now, with the successful establishment of the MMRC Tissue Bank, researchers for the first time have access to the critical mass of high-quality tissue needed to rapidly validate novel and combination therapies for myeloma. The MMRC Tissue Bank is the only resource of its kind that integrates myeloma tissue samples with corresponding genomic and clinical data. To date, the MMRC Tissue Bank has accrued more than 2,700 samples with matching peripheral blood samples, with ongoing collection of tissue samples at Member Institutions nationwide. To further accelerate accrual, the MMRC has also launched a direct-to-patient program to enable myeloma patients to donate their tissue to the MMRC Tissue Bank. Notably, all tissue accrued into the MMRC Tissue Bank is uniformly collected and stored in adherence with Good Laboratory Practices (GLP) standards and under the governance of more than 50 standard operating procedures. The MMRC has also established a quality assurance unit that performs weekly internal quality assurance reviews and issues quarterly quality assurance reports. In addition, the MMRC Tissue Bank has been audited twice by external organizations since its inception last year. With these stringent practices in place, the MMRC has ensured that all tissue samples in the MMRC Tissue Bank are of the very highest-quality and, as such, has quickly become the premier resource for industry seeking fresh tissue samples to initiate strong validation work.

Proper citation: Myeloma Tissue Bank (RRID:SCR_004291) Copy   

•   Source: SciCrunch Registry

http://www.lifealaska.org/

Life Alaska Donor Services is the tissue donation organization serving the state of Alaska, offering the option of donation to families who have suffered a death in Alaska. Life Alaska was established in 1991 as the state''s tissue donation program. Since that time, Life Alaska has had many donors and has supplied thousands of tissues for transplantation to Alaskan patients. Life Alaska works in partnership with the federally designated Organ Procurement Organization in Washington (LifeCenter Northwest) to provide education on tissue and organ donation throughout the state. Tissue donations have taken place across the state, from Barrow to Ketchikan. The age criteria for transplantable tissues and organs are generally from birth to 80 years of age, with patients of any age being candidates for research. Tissues donated to Life Alaska are first offered to Alaskan patients and physicians before being made available outside the state. Organs are shared using the federally mandated national sharing system operated by the United Network for Organ Sharing and are first offered to transplant centers in the Pacific northwest.

Proper citation: Life Alaska Donor Services, Inc. (RRID:SCR_004242) Copy   

•   Source: SciCrunch Registry

http://americandonorservices.org/

American Donor Services (ADS) is an independent, non-profit organization specializing in tissue donation. Its mission is to improve lives through the gift of donation. ADS honors the spirit of donation by providing caring support to donor families, employing competent staff, and partnering with organizations that are dedicated to the innovative use of tissue for transplantation and research. We are registered with the Food and Drug Administration (FDA). ADS is also accredited with the American Association of Tissue Banks (AATB) and employs dedicated and experienced leadership and staff to sustain our program. The fundamental objective of ADS is to provide the opportunity of donation to individuals who have designated themselves as a donor and families who have the inclination and the potential to have their loved one become a tissue donor. ADS is dedicated to the cause of all donations and as such will support all other organizations in their parallel undertakings. We are committed to providing the best possible serivce to our Donor Families, Hospitals, Medical Donate Life Examiners, Coroners and Funeral Professionals.

Proper citation: American Donor Services (RRID:SCR_004241) Copy   

•   Source: SciCrunch Registry

http://spin.chip.org/

THIS RESOURCE IS NO LONGER IN SERVICE, documented August 31, 2016. The Dana-Farber/Harvard Cancer Center Pathology Specimen Locator (PSL) is a core developed to facilitate translational research requiring human specimens. The PSL is a distributed network of databases containing de-identified pathology reports and other specimen information from IRB-approved repositories within Dana-Farber/Harvard Cancer Center affiliated institutions. Using the PSL, researchers can work with the pathology departments to find appropriate specimens for their research. The Harvard VLS currently contains approximately two million de-identified pathology reports from the four main Harvard Teaching Hospitals.

Proper citation: Dana Farber Tissue Bank (RRID:SCR_004352) Copy   

•   Source: SciCrunch Registry

http://www.biooptions.com/

BIO - OPTIONS provides human tissues and biological materials to researchers and scientists for molecular and genomic research. These high quality, well characterized biological specimens are available for drug and biomarker discovery, validation of drug targets and development of diagnostic tests and devices. BIO - OPTIONS specializes in providing fresh tumor tissue, blood and other biological fluids delivered the same day or overnight for your studies. We collect specimens from virtually all disease states through our extensive network of physicians, hospitals, and clinical laboratories. All of our specimens are collected at facilities located in the United States in compliance with all applicable federal and state laws and regulations and ethical guidelines. Collection facilities are located on the East and West coasts and Midwest. The officers of BIO - OPTIONS consist of licensed physicians with extensive medical training and experience. This enables us to work directly with physicians and support staff to insure that collection protocols provide the high quality specimens needed for research without compromising patient care. Protocols are designed to work within the workflow of physician offices and hospital operating rooms so that specimens are timely processed and preserved and well characterized.

Proper citation: Bio-Options (RRID:SCR_004594) Copy   

•   Source: SciCrunch Registry

http://www.shca.org.cn/english/content/11540

The Institutional Tissue Bank (ITB) of Fudan University Shanghai Cancer Center was established in 2006 with the goal of serving as a central repository for human tissue samples for cancer research and possible personalized medicine for the institution. The Institutional Research Board oversees the fulfilling of informed consent of each patient whose samples are collected. The ITB''s collection procedures meet the global quality standards and provide high quality tissue samples. The quality control for morphology, RNA, DNA and protein has been set up to ensure the sample quality. Routine frozen section from tissue aliquot is made for every piece of sample to ensure the component of tumor tissue and the pathological feature is the same as the diagnosed tumor. Agilent 2100 Bioanalyzer was used to provide RNA and DNA quality parameters. The Tissue Bank occupies 500 m2, with sufficient space for sample preparation and storage, data registration, data tracking/access, related equipments and monitor system. Variant samples including blood, tumor tissue, and body fluids are collected and serve as alternative permanent patient tissue records. Annotation of collected samples is captured through linking the medical record and pathological report system to tissue bank software. Frequent tumor types such as lung cancer, breast cancer, gastric cancer, urological tumors, gynecological tumors and esophageal cancers, head & neck cancers, as well as infrequent cancer types such as malignant soft tissue sarcomas, pancreatic cancer, gall bladder cancer, and other rare cancers are all collected and stored. Tumor tissues are stored with matched normal tissues. Serum and plasma are isolated from coagulation plus and coagulation minus blood samples. White blood cells are stored as well. Tissues are stored both in RNALater at -20 degrees C and -80 degrees C after snap frozen. Samples have been increased from 4,000 in 2008 to 10,783 in 2009. To the end of September 2010, over 30,000 samples has been processed and stored in our tissue bank. As planned, 50,000 samples will be stored dynamically. Over 50 funded projects have used the samples from our tissue bank. Productive papers have been published in the past years by using the samples. More and more projects will be approved to get research resources from tissue bank in the future. The tissue bank of FUSCC has been designated as the key subject and successful model by Shanghai municipal government.

Proper citation: Cancer Center Tissue Bank - Fudan University (RRID:SCR_004596) Copy   

•   Source: SciCrunch Registry

http://www.lifepoint-sc.org

Certified by the federal government, LifePoint is the designated Organ Procurement Organization (OPO) for organ recovery services in South Carolina, excepting Aiken and Edgefield counties. LifePoint actively provides organ, tissue and ocular donor services to 62 hospitals throughout the state. We offer professional education about donation to the hospital staff members in order to maximize the amount and quality of donated organs and tissues. LifePoint also helps support and educate families at an emotionally devastating time, so they can make well-informed decisions about organ and tissue donation. Whether they decide for or against donation, our aim is to assure that they will feel they have made the right decision in the months and years to come.

Proper citation: LifePoint, Inc. (RRID:SCR_004235) Copy   

•   Source: SciCrunch Registry

http://www.dohenyeyebank.org/

The community-based Doheny Eye & Tissue Transplant Bank has become a pioneer and leader in providing eye and tissue banking services to patients, surgeons and hospitals in southern California for more than 40 years. The mission of the Doheny Eye & Tissue Transplant Bank is to relieve human suffering by providing human tissue for transplant, research, and medical education in our community and around the world. The non-profit, non-governmental Doheny Eye & Tissue Bank is a member of the TBI/Tissue Banks International non-profit network of vision and certified by Eye Bank Association of America.

Proper citation: Doheny Eye and Tissue Transplant Bank (RRID:SCR_004350) Copy   

•   Source: SciCrunch Registry

http://www.beadonor.org

Founded in 1986, Washington Regional Transplant Community (WRTC) is federally designated as the organ procurement organization (OPO) for Washington, DC, Northern Virginia and suburban Maryland since 1988. This non-profit organization provides full-service organ, tissue and eye recovery. WRTC responds to potential donors at more than 44 area healthcare institutions and serves approximately 5.13 million Washington-area residents. It coordinates with all five area transplant centers and the United Network for Organ Sharing (UNOS). WRTC provides support to more than 4,000 donor family members and acts as the community and professional education resource for organ and tissue donation in the Washington, DC, region.

Proper citation: Washington Regional Transplant Community - WRTC (RRID:SCR_004628) Copy   

•   Source: SciCrunch Registry

http://www.donoralliance.org

Donor Alliance is one of 58 not-for-profit organ recovery organizations federally designated by the U.S. Department of Health & Human Services to facilitate the donation and recovery of organs for people needing transplants. Additionally, Donor Alliance is a recognized leader in facilitating the donation and recovery of transplantable tissues in Colorado and most of Wyoming. Our goal is to save the lives of people in need. To achieve this, Donor Alliance employs effective family approach and recovery programs in more than 100 hospitals in Colorado and Wyoming. Additionally, Donor Alliance dedicates time, funding and effort toward increasing the number of registered organ and tissue donors through active public awareness and educational programs and grassroots public relations campaigns.

Proper citation: Donor Alliance (RRID:SCR_004265) Copy   

•   Source: SciCrunch Registry

http://cancer.case.edu/sharedresources/tissue/

THIS RESOURCE IS NO LONGER IN SERVICE. Documented on January 11, 2023. The Case Comprehensive Cancer Center''s Biorepository and Tissue Processing Core Facility (BTPC) serves two primary functions: 1. To build an inventory of remnant human tissues, blood and other body fluids (collectively termed biospecimens) targeted towards cancer and other medical research, for later assignment to investigators; and 2. To provide long term, controlled storage of biospecimens for specific researchers. These samples are for research purposes only and may not be used for clinical diagnosis or implantation into humans. Clinical information relating to the samples and donors are collected and maintained in a secure database. Samples and data are de-identified or de-linked before release to the researcher unless he/she has specific IRB approval to gain access to this information. Remnant biospecimens are prospectively collected from surgical procedures, autopsies and clinical laboratories for the BTPC by the Human Tissue Procurement Facility (HTPF), which operates under UH-IRB Protocol 01-02-45. Blood and bone marrow specimens are collected for the BTPC by the Hematopoietic Stem Cell Core Facility (HSCC), which operates under UH-IRB Protocol 09-90-195. The Division of Surgical Pathology at University Hospitals Case Medical Center (UHCMC) has clinical archives of paraffin blocks that can be made available through the BTPC for retrospective research studies under the approval of the Vice Chair for Clinical Affairs at UHCMC. Surgical Pathologists associated with the BTPC are responsible for determining which blocks can be made available and how much material can be removed from the blocks. Types of Tissue Available * Malignant, benign, diseased, normal and normal human tissues * Normal adjacent tissues available paired with tumor specimens in many cases * Tissues are collected from over 50 anatomic sites * Frozen specimens, OCT-embedded and paraffin-embedded tissues * Large array of paraffin-embedded specimens from clinical archives of paraffin blocks and QC research blocks maintained by the HTPF * Peripheral blood and bone marrow samples from initial visits and follow-up procedures are processed to obtain serum and cell fractions for storage * No samples are collected from individuals with known infectious illnesses * Fetal biospecimens are not collected due to state and local statutes

Proper citation: Case Comprehensive Cancer Center Biorepository and Tissue Processing Core Facility (RRID:SCR_004382) Copy   

•   Source: SciCrunch Registry

http://www.uclaaidsinstitute.org/researchareas/clinical_malignancy.php

THIS RESOURCE IS NO LONGER IN SERVICE, documented on February 27, 2012. The National Cancer Institute established centers in the United States and its territories for the collection and distribution of tissues, blood and secretions from patients with clinically-characterized AIDS related malignancies in 1994. The AIDS Malignancy Bank makes these tissues available to qualified investigators in the United States for research on AIDS malignancies. It is hoped that by providing access to these high-quality specimens, research in AIDS-related malignancies will be encouraged and expanded. The AMB contains formalin-fixed paraffin-embedded tissues, fresh-frozen tissues, malignant-cell suspensions, fine-needle aspirates, and cell lines from AIDS-related malignancies. The bank also contains serum, plasma, urine, bone marrow, cervical secretions, anal swabs, saliva semen and multi-site autopsy tissues from patients with AIDS-related malignancies who have participated in clinical trials. The bank has an associated database that contains prognostic, staging, outcome and treatment data on patients from whom tissues were obtained. Researchers pay for preparation and shipping of specimens.

Proper citation: AIDS Malignancy Bank (RRID:SCR_004417) Copy   

•   Source: SciCrunch Registry

http://www.procure.ca/en/biobank/

PROCURE proposes to enable the collection and storage of standardized high volumes of prostatic tissues, blood, urine, clinical information and socio-demographic data from men undergoing prostate cancer screening and surgery across the province of Quebec and facilitate access to these resources. PROCURE will make the Biobank materials and information available to the global scientific community to facilitate the implementation of studies at an accelerated pace. Informed consent, upholding full confidentiality, will be sought from the thousands of men already undergoing prostate biopsies and radical prostatectomies in Quebec each year. Quebec is an ideal location to conduct this initiative with its diverse ethnic groups and low migration. The low migration will allow for repeated follow-up with individuals. This large collection of biospecimen and information will be used for biochemical and genetic analysis with great statistical power and will facilitate learning about the manifestation and progression of prostate cancer over time. Additional benefits include the acceleration of clinical trials, better prevention, earlier detection and diagnosis, the development of personalized medicine, more efficacious treatment, and follow-up care. The Biobank is a collaborative organization with long term partnerships established between PROCURE, the four Qu��������bec universities (McGill University, Universit�������� de Sherbrooke, Universit�������� Laval, Universit�������� de Montr��������al), with the Fonds de recherche en sant�������� du Qu��������bec and other key groups to be confirmed over time.

Proper citation: PROCURE Quebec Prostate Cancer Biobank (RRID:SCR_004411) Copy   

•   Source: SciCrunch Registry

http://www.ntnu.edu/lbk/biobank

The Regional Biobank of Central Norway, henceforth called the Biobank, is a research facility which contains a collection of human biological material such as blood, tissue and urine samples, and a database which stores relevant information about the samples and the patients from whom the samples originate, as well as information obtained from analysis of the material. The material is collected as part of medical examinations, diagnosis or treatment. The Biobank is foreseen to give an increased knowledge about causes for diseases and their mechanisms, and thereby contributing to improve prophylactic health work, diagnostics and treatment. The Biobank is owned and operated by official authorities on a no commercial profit basis. The Biobank was established in collaboration between the Central Norwegian Regional Health Authority (data management and administration) and the Faculty of Medicine at the Norwegian University of Science and Technology (economics and personnel). The Biobank is approved by The Data Inspectorate of Norway, and by the Regional Committee for Medical Research Ethics, and all information in the Biobank is handled according to the guidelines of the Data Inspectorate.

Proper citation: Regional Biobank of Central Norway (RRID:SCR_004534) Copy   

•   Source: SciCrunch Registry

http://www.startthecure.com/clinical_tumor_bank.php

Biospecimen repository for tumor specimens, available to all researchers actively engaged in cancer research whether they are in University, Academic, or Pharmaceutical industry, with a goal to accelerate the discovery and development of new agents for the treatment and cure of cancer. The START tumor bank was created to make tumor tissue gifted by patients receiving care or treatment at The START Center available to all researchers involved in developing a better understanding of the biology of cancer or those engaged in the discovery of new therapies. The START Tumor Bank is a department within the PK Department and handles skin and tumor biopsies required by clinical trial protocols. A member of the PK Department is present during biopsy procedures for immediate processing of the sample for the trial. Additionally, the Tumor Bank collects and banks the tumor tissues of patients who consent. This tissue is then stored for future use by researchers developing new therapies.

Proper citation: START Tumor Bank (RRID:SCR_004258) Copy   

•   Source: SciCrunch Registry

http://www.clinicbiobanc.org/en_index.html

A biobank of repositories which works to obtain, store, manage and distribute large collections of human biological samples of phenotypes and diseases of marked interest for researchers. The biobank sample collection is made up of three extensive repositories. The Neurological Tissue Biobank is a nervous tissue repository (brain and spinal cord) created from donations from cadavers with or without neurological conditions. It helps facilitate research in neurological illnesses. The Tumour Biobank and Anatomical Pathologies Collections is a repository of tumorous tissue and samples from cancer patients. The Blood and Fluid Biobank is a repository which contains samples of metabolic, inflammatory bowel, hepatic, digestive and maternal and foetal diseases, among others. It houses a large range of samples of scientific interest, primarily DNA, serum and plasma.

Proper citation: Biobank of Hospital Clinic - IDIBAPS (RRID:SCR_004530) Copy   

•   Source: SciCrunch Registry

https://www.pathology.umn.edu/research/liver-tissue-cell-distribution-system

Tissue bank that provides human liver tissue from regional centers for distribution to scientific investigators throughout the United States. These USA regional centers have active liver transplant programs with human subjects approval to provide portions of the resected pathologic liver for which the transplant is performed.

Proper citation: Minnesota Liver Tissue Cell Distribution System (RRID:SCR_004840) Copy   

•   Source: SciCrunch Registry